Kewaunee Scientific Corp /De/ (KEQU): who owns it and who trades it
As of Nov 12, 2026, KEQU insiders reported 7 open-market sales worth $293K and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Thomas David Hull III (CEO), with $218K. 1 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 12, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Kewaunee Scientific
From the latest filingsOverall: more selling than buying. Insiders and famous investors mostly sold. Funds mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns KEQU
32 funds and institutions reported KEQU shares worth $42.6M at the end of Q2 2026, about 42% of the company. The largest holder is Northern Trust Corp with 8.3%.
Funds and institutions (13F) 42%Everyone else 58%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Northern Trust Corp | 238,111 | 8.30% | $8.5M | -3% |
| Dimensional Fund Advisors LP | 175,042 | 6.10% | $6.2M | -1% |
| Minerva Advisors LLC | 149,410 | 5.21% | $5.3M | +9% |
| Vanguard Capital Management LLC | 110,051 | 3.83% | $3.9M | -2% |
| Punch & Associates Investment Management, Inc. | 105,545 | 3.68% | $3.7M | +5% |
| Renaissance Technologies LLC | 95,311 | 3.32% | $3.4M | -3% |
| De Lisle Partners LLP | 52,626 | 1.83% | $1.9M | No change |
| Royce & Associates LP | 49,700 | 1.73% | $1.8M | +4% |
| American Century Companies Inc | 49,530 | 1.73% | $1.8M | No change |
| Geode Capital Management, LLC | 24,931 | 0.87% | $886K | +2% |
| Mink Brook Asset Management LLC | 21,447 | 0.75% | $762K | No change |
| Northeast Investment Management | 20,000 | 0.70% | $710K | No change |
| Morgan Stanley | 16,828 | 0.59% | $598K | -16% |
| Vanguard Fiduciary Trust Co | 13,172 | 0.46% | $468K | +1% |
| Wealth Enhancement Advisory Services, LLC | 12,694 | 0.44% | $465K | No change |
| BlackRock, Inc. | 11,978 | 0.42% | $425K | +21% |
| Bridgeway Capital Management, LLC | 11,815 | 0.41% | $420K | No change |
| State Street Corp | 10,034 | 0.35% | $356K | No change |
| Verdad Advisers, LP | 10,000 | 0.35% | $355K | New |
| LPL Financial LLC | 8,000 | 0.28% | $284K | No change |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, KEQU insiders reported $0 of open-market purchases and $293K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | Thomas David Hull III | CEO | Sale | 2,177 | $37.50 | $81.6K | Form 4 |
| Jan 6, 2026 | Donald T. Gardner III | CFO | Sale | 2,000 | $37.57 | $75.1K | Form 4 |
| Dec 31, 2025 | Thomas David Hull III | CEO | Sale | 629 | $37.66 | $23.7K | Form 4 |
| Dec 30, 2025 | Thomas David Hull III | CEO | Sale | 29 | $38.00 | $1.1K | Form 4 |
| Dec 29, 2025 | Thomas David Hull III | CEO | Sale | 884 | $38.01 | $33.6K | Form 4 |
| Dec 22, 2025 | Thomas David Hull III | CEO | Sale | 1,000 | $39.00 | $39K | Form 4 |
| Dec 17, 2025 | Thomas David Hull III | CEO | Sale | 1,000 | $39.00 | $39K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Thomas David Hull III | President, CEO, Director | – | $218K | Jan 7, 2026 |
| Donald T. Gardner III | Chief Financial Officer | – | $75.1K | Jan 6, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
KEQU short interest
Low short interest. 1.3% of KEQU shares are sold short: about 1 share in 76. Over the last 12 reports the number of shares short went down 10%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 38,286 KEQU shares were sold short, 1.3% of the shares outstanding, down 3.4% from the report before. At the average daily volume of 2,667 shares, buying them all back would take about 14.4 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 38,286 | 1.32% | -3% | 2,667 | 14.4 |
| Oct 15, 2026 | 39,627 | 1.37% | -10% | 4,547 | 8.7 |
| Sep 30, 2026 | 43,957 | 1.52% | -10% | 5,468 | 8.0 |
| Sep 15, 2026 | 48,909 | 1.69% | +3% | 3,673 | 13.3 |
| Aug 31, 2026 | 47,583 | 1.66% | +7% | 1,913 | 24.9 |
| Aug 14, 2026 | 44,564 | 1.55% | -6% | 3,510 | 12.7 |
| Jul 31, 2026 | 47,578 | 1.66% | -2% | 5,777 | 8.2 |
| Jul 15, 2026 | 48,323 | 1.68% | -4% | 5,053 | 9.6 |
| Jun 30, 2026 | 50,399 | 1.76% | +15% | 9,244 | 5.5 |
| Jun 15, 2026 | 43,667 | 1.52% | +5% | 2,625 | 16.6 |
| May 29, 2026 | 41,532 | 1.45% | -2% | 2,593 | 16.0 |
| May 15, 2026 | 42,390 | 1.48% | -6% | 1,930 | 22.0 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Kewaunee Scientific company events
Kewaunee Scientific filed 12 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Nov 2, 2026.
- Nov 2, 2026AgreementKewaunee Scientific Corporation entered into a Securities Purchase Agreement, dated as of the Signing Date, by and among the Company, NYCOM, Inc., and the seller parties set forth on the signature pages thereto, pursuant to which the Company agreed to acquire NYCOM, subject to the terms and… Filing
- Sep 9, 2026ResultsReleased financial results. Filing
- Aug 27, 2026VoteReported shareholder vote results. Filing
- Aug 26, 2026AnnouncementShared information with investors. Filing
- Aug 25, 2026AnnouncementKewaunee Scientific Corporation announced that the Company plans to release its first quarter fiscal 2027 earnings on September 9, 2026. Filing
- Jun 23, 2026ResultsReleased financial results. Filing
- Jun 10, 2026AnnouncementKewaunee Scientific Corporation announced that the Company plans to release results for its fourth quarter and fiscal year ended April 30, 2026 on June 23, 2026. Filing
- Mar 11, 2026ResultsReleased financial results. Filing
- Feb 25, 2026AnnouncementKewaunee Scientific Corporation announced that the Company plans to release its third quarter fiscal 2026 earnings on March 11, 2026. Filing
- Dec 10, 2025ResultsReleased financial results. Filing
- Dec 4, 2025AgreementKewaunee Scientific Corporation entered into a First Amendment to Loan Agreement with PNC Bank, National Association. Filing
- Nov 26, 2025AnnouncementKewaunee Scientific Corporation announced that the Company plans to release its second quarter fiscal 2026 earnings on December 10, 2025. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Kewaunee Scientific financials
Famous investors that hold KEQU
1 of the 50 well-known investors we track reported holding KEQU in their latest 13F filing. The largest position is Jim Simons's, worth $3.1M.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Jim Simons · Renaissance Technologies | Q3 2026 | 90,911 | $3.1M | 0.0% | -5% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Kewaunee Scientific Corp /De/ (KEQU) stock
Who owns the most KEQU stock?
The largest reported owner of Kewaunee Scientific Corp /De/ (KEQU) is Northern Trust Corp, with 8.3% of the company. In total, 32 funds and institutions reported holding KEQU at the end of Q2 2026, together about 42% of the shares. See the largest owners.
Are KEQU insiders buying or selling?
In the last 12 months, KEQU insiders reported no open-market purchases and 7 sales worth $293K. The latest trade was on Jan 7, 2026. See every trade.
What is the short interest in KEQU?
As of Oct 30, 2026, 38,286 KEQU shares were sold short, 1.3% of the shares outstanding, down 3.4% from the report before. At the average daily volume of 2,667 shares, buying them all back would take about 14.4 trading days (days to cover). See the history.
Which famous investors hold KEQU?
1 of the 50 well-known investors we track reported KEQU in their latest 13F filing, including Jim Simons. The largest position is worth $3.1M. See all holders.
Executive pay
Kewaunee Scientific's chief executive was paid a total of $2M for the year ended Apr 30, 2026, up 9% from $1.8M the year before. In the last 12 months, Kewaunee Scientific's executives and directors bought no stock on the open market and sold $293K.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.